30-day mortality   30-day outcome
  All Patients,
n=175
No, n= 119 Yes, n= 56 P value Better (GOS 4-5), n= 78 Worse (GOS 2-3), n= 41 P value
Age, y (SD) 66.3 (11.8) 65.7 (11.6) 67.7 (12.3) 0.2930 63.8 (10.1) 69.2 (13.4) 0.0139
Male sex, n (%) 103 (58.9) 69 (58.0) 34 (60.7) 0.7320 43 (55.1) 26 (63.4) 0.3841
Vascular risk factors                        
Arterial hypertension, n (%) 143 (81.7) 98 (82.3) 45 (80.4) 0.7512 63 (80.8) 35 (85.4) 0.5319
Diabete mellitus, n (%) 50 (28.6) 28 (23.5) 22 (39.3) 0.0314 20 (25.6) 8 (19.5) 0.4538
Alcohol abuse, n (%) 40 (22.9) 24 (20.2) 16 (28.6) 0.0223 16 (20.5) 8 (19.5) 0.9923
Cigarette smoking, n (%) 52 (29.7) 37 (31.1) 15 (26.8) 0.1586 16 (39.0) 21 (26.9) 0.3969
Hypercholesterolemia, n (%) 50 (28.6) 32 (26.9) 18 (32.1) 0.2962 24 (30.8) 8 (19.5) 0.4185
Clinical characteristics                        
GCS score, median (25th –75th) 13 (9-15) 14 (13-15) 7 (4-10) <0.0001 15 (14-15) 12 (11-14) <0.0001
oICH score, median (25th –75th) 1 (1-3) 1 (0-2) 3 (3-4) <0.0001 1 (0-1) 1 (1-3) <0.0001
Pupillary abnormalities,* n (%) 29 (16.6) 3 (2.5) 26 (46.4) <0.0001 1 (1.3) 2 (4.9) 0.2344
Radiological variables                        
Localization of the SICH, n (%)             0.5039         0.0148
Basal ganglia 56 (32.0) 38 (31.9) 18 (32.1)   18 (23.1) 20 (48.8)  
Thalamic 13 (7.4) 11 (9.2) 2 (3.6)   9 (11.5) 2 (4.9)  
Lobar 47 (26.9) 32 (26.9) 15 (26.8)   25 (32.1) 7 (17.0)  
Pontine 50 (28.6) 32 (26.9) 18 (32.1)   20 (25.6) 12 (29.3)  
Cerebellar 8 (4.6) 6 (5.0) 2 (3.6)   6 (7.7) 0 -  
Other 1 (0.5) 0 - 1 (1.8)   - - - -  
Volume cc, median (25th –75th) 20 (9-40) 15 (7-24) 40 (21-70) <0.0001 9.5 (6-16) 22 (16-30) <0.0001
Midline shift, mm             <0.0001         0.2194
0-5 141 (80.6) 114 (95.8) 27 (48.2)   76 (97.4) 38 (92.7)  
6-9 19 (10.8) 5 (4.2) 14 (25.0)   2 (2.6) 3 (7.3)  
10-14 11 (6.3) 0 - 11 (19.6)   - - - -  
>15 4 (2.3) 0 - 4 (7.1)   - - - -  
IVH 83 (47.4) 38 (31.9) 45 (80.4) <0.0001 19 (24.4) 19 (46.3) 0.0145
Graeb’s score, median (25th –75th) 4 (3-7) 3 (2-5) 6 (3-8) 0.0012 3 (2-4) 4 (3-7) 0.0278
Hydrocephalus 55 (31.4) 20 (16.8) 35 (62.5) <0.0001 8 (10.3) 12 (29.3) 0.0084
Biochemistry and vital signs on hospital arrival                        
Plasma glucose, mmol/l (SD) 8.75 (4.13) 7.62 (3.50) 11.14 (4.36) <0.0001 7.96 (3.98) 7.02 (2.38) 0.0600
WBC, x109/l median (25th –75th) 8.0 (6.5-9.9) 7.3 (5.7-8.8) 9.9 (8.7-
14.0)
<0.0001 6.8 (5.7-8.7) 7.6 (6.5-9.8) 0.1034
CRP, mg/l median (25th –75th) 9.0 (5-17.1) 8.0 (5.0-
13.5)
10.6 (6.5-
19.6)
0.0747 8.5 (5.0-19.0) 7.8 (4.7-11.0) 0.2308
Ipoxemia,(%) 31 (17.7) 5 (4.2) 26 (46.4) <0.0001 0 - 5 (12.2) 0.0016
SBP, mmHg (SD) 172 (40) 175 (36) 166 (48) 0.2462 177 (35) 172 (39) 0.4275
DBP, mmHg (SD) 96 (22) 98 (21) 94 (24) 0.3324 97 (19) 98 (24) 0.8769
PP, mmHg (SD) 76 (25) 77 (24) 73 (27) 0.3142 80 (23) 73 (25) 0.0763
Therapy                        
Surgery 39 (22.3) 19 (16.0) 20 (35.7) 0.0034 10 (12.8) 9 (21.9) 0.1963
GCS score indicates Glasgow Coma Scale score;ICH intracerebral hemorrhage; IVH intraventricular hemorrhage. *Pupillar abnormalities include pupillary inequality (anisocoria) or bilateral miosis and/or midirasis. †Prehospital hypoxemia includes cianosis, apnea or SaO2<90 mmHg
Table 1: Baseline characteristics and potential baseline factors associated with 30-day mortality and 30-day outcome.